1. Home
  2. ASH vs IMNM Comparison

ASH vs IMNM Comparison

Compare ASH & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ashland Inc.

ASH

Ashland Inc.

HOLD

Current Price

$53.03

Market Cap

2.4B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.45

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASH
IMNM
Founded
1924
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
ASH
IMNM
Price
$53.03
$19.45
Analyst Decision
Buy
Strong Buy
Analyst Count
7
10
Target Price
$65.57
$32.80
AVG Volume (30 Days)
578.4K
1.1M
Earning Date
04-29-2026
03-03-2026
Dividend Yield
3.06%
N/A
EPS Growth
N/A
51.40
EPS
N/A
N/A
Revenue
$1,824,000,000.00
$6,941,000.00
Revenue This Year
$2.52
N/A
Revenue Next Year
$3.74
$1,127.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.21
$5.15
52 Week High
$65.65
$27.65

Technical Indicators

Market Signals
Indicator
ASH
IMNM
Relative Strength Index (RSI) 43.98 36.87
Support Level $47.57 $19.26
Resistance Level $54.56 $22.57
Average True Range (ATR) 1.73 1.05
MACD 0.43 -0.04
Stochastic Oscillator 64.92 1.41

Price Performance

Historical Comparison
ASH
IMNM

About ASH Ashland Inc.

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: